Tag

Antiviral Pill

All articles tagged with #antiviral pill

"Promising Trial of First Dengue Fever Prevention Pill Amid Growing U.S. Fears"
health2 years ago

"Promising Trial of First Dengue Fever Prevention Pill Amid Growing U.S. Fears"

Johnson & Johnson has presented promising data on an antiviral pill, JNJ-1802, that appears to protect against dengue fever in a clinical trial. The trial involved healthy volunteers who were exposed to a type of dengue virus after taking the drug or a placebo. While all participants in the placebo group showed signs of infection, six out of ten participants receiving a high dose of the drug showed no signs of infection. The results offer hope for a future treatment against dengue, a growing health threat worldwide. Johnson & Johnson plans to conduct larger tests and is currently running a Phase 2 clinical trial in ten countries to assess the drug's ability to prevent dengue from all four strains of the virus.

Pfizer's Paxlovid receives full FDA approval for high-risk COVID treatment.
health3 years ago

Pfizer's Paxlovid receives full FDA approval for high-risk COVID treatment.

The FDA has granted full approval to Pfizer's Covid antiviral pill, Paxlovid, for adults who are at high risk of getting severely sick with the virus. Paxlovid is specifically advised for the treatment of mild to moderate Covid in adults older than 50 and people who suffer from certain medical conditions that place them at a higher risk of ending up in the hospital or dying from Covid. The treatment consists of two medications: nirmatrelvir and ritonavir. Both Pfizer and the FDA view the treatment as an important complementary tool to vaccination that can help high-risk Americans manage their Covid infections and ultimately save lives.

FDA advisers endorse Paxlovid for Covid treatment in high-risk adults.
health3 years ago

FDA advisers endorse Paxlovid for Covid treatment in high-risk adults.

The FDA's independent panel of advisors has recommended full approval of Pfizer's Covid-19 antiviral pill Paxlovid for high-risk adults, but flagged potentially harmful drug interactions. The treatment is advised for people over 50 or those who suffer from medical conditions such as high blood pressure or diabetes that place them at a higher risk of ending up in the hospital or dying from Covid. The FDA typically follows the advice of its advisory committees but is not required to do so. It is slated to make a final decision in May.